Abstract:Introduction: TP53 -induced glycolysis and apoptosis regulator (TIGAR) is a p53 target protein that has critical roles in glycolysis and redox balance. The reports about the effect of TIGAR on prognosis and its biological role in hepatocellular carcinoma (HCC) are limited. Methods: A total of 386 patients with HCC who had undergone hepatic resection were enrolled. Immunohistochemical staining for TIGAR was performed. Additionally, the regulation of malignant activity and ferroptosis by TIGAR was investigated in vitro. Results: Patients were divided into TIGAR-positive ( n = 80, 20.7%) and -negative ( n = 306, 79.3%) groups. TIGAR positivity was significantly correlated with lower albumin, higher α-fetoprotein/ des -gamma-carboxyprothrombin, larger tumor size/number of tumors, and greater proportions of BCLC staging C/single nodular type/poor differentiation/microscopic vascular invasion/microscopic intrahepatic metastasis. In multivariate analysis, TIGAR positivity was an independent prognostic factor ( p < 0.0001). In addition, TIGAR positivity was significantly associated with a smaller number of cluster of differentiation (CD) 8-positive T cells ( p = 0.0450), larger number of CD68-positive macrophages ( p = 0.0058), larger number of programmed death-ligand 1-positive cases ( p = 0.0002), and larger number of vessels that encapsulate tumor cluster-positive cases ( p = 0.0004). In vitro, TIGAR knockdown decreased cell motility and induced ferroptosis. TIGAR knockdown inhibited the phosphorylation of adenosine monophosphate-activated protein kinase and acetyl-CoA carboxylase. Ferroptosis induced by TIGAR knockdown was inhibited by liproxstatin and baicalein treatment. The combination of TIGAR knockdown and lenvatinib further induced ferroptosis. Conclusion: High expression of TIGAR impacted the clinical outcome of HCC patients and TIGAR was associated not only with tumor microenvironment but also with resistance to ferroptosis.

The Diverse Role of TIGAR in Cellular Homeostasis and Cancer

Structure, regulation, and biological functions of TIGAR and its role in diseases

TIGAR promotes malignant proliferation of NSCLC by modulating deoxynucleotide anabolism via a YBX1-RRM2B axis

JMJD5 Inhibits Lung Cancer Progression by Regulating Glucose Metabolism Through the P53/tigar Pathway

TP53-inducible Glycolysis and Apoptosis Regulator (TIGAR) Metabolically Reprograms Carcinoma and Stromal Cells in Breast Cancer

TIGAR Regulates DNA Damage and Repair Through Pentosephosphate Pathway and Cdk5-ATM Pathway

TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Is Upregulated in Lymphocytes Stimulated with Concanavalin A

The Role of TIGAR in Nervous System Diseases

Knockdown of the TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Sensitizes Glioma Cells to Hypoxia, Irradiation and Temozolomide

Immune landscape of hepatocellular carcinoma: The central role of TP53-inducible glycolysis and apoptosis regulator

TP53 Induced Glycolysis and Apoptosis Regulator and Monocarboxylate Transporter 4 drive metabolic reprogramming with c-MYC and NFkB activation in breast cancer

TIGAR Alleviates Ischemia/reperfusion-Induced Autophagy and Ischemic Brain Injury.

Nuclear TIGAR mediates an epigenetic and metabolic autoregulatory loop via NRF2 in cancer therapeutic resistance

Metabolic Remodeling by TIGAR Overexpression is a Therapeutic Target in Esophageal Squamous-Cell Carcinoma

TIGAR drives colorectal cancer ferroptosis resistance through ROS/AMPK/SCD1 pathway

TIGAR Enhanced Free Ca2+ Concentration in Hepatocellular Carcinoma Cells to Accelerate the Sustained Proliferation and Drug Resistance

Knockdown of TIGAR by RNA Interference Induces Apoptosis and Autophagy in HepG2 Hepatocellular Carcinoma Cells.

The Impact of TP53-Induced Glycolysis and Apoptosis Regulator on Prognosis in Hepatocellular Carcinoma: Association with Tumor Microenvironment and Ferroptosis

TP53, TP53 Target Genes (DRAM, TIGAR), and Autophagy.

Data Supplement from TIGAR Has a Dual Role in Cancer Cell Survival Through Regulating Apoptosis and Autophagy

The fundamental role of the p53 pathway in tumor metabolism and its implication in tumor therapy.